ACM
GRI

Altium Capital Management’s GRI Bio GRI Stock Holding History

Altium Capital Management’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30
Closed -$143K – 74
2024
Q1 		$143K Buy
+30
New +$256K 0.06% 50
2023
Q4 		– Sell
-12
Closed -$808K – 76
2023
Q3 		$808K Sell
12
-15
-56% -$1.7M 0.42% 41
2023
Q2 		$5.01M Buy
+27
New +$8.89M 3.79% 9
2021
Q3 		– Hold
0
– -$878K – 135
2021
Q2 		– Hold
0
– – – 115
2021
Q1 		– Hold
0
– – – 94

Other funds holding GRI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Altium Capital Management's GRI Position: Q2 2024 in Review

Altium Capital Management sold out of GRI Bio (GRI) in Q2 2024, closing a stake of 30 shares — an estimated $143K sold.

Altium Capital Management first reported a position in GRI in Q2 2023 and held it in 3 quarters. The position peaked at $5.01M in Q2 2023. 4 funds tracked by Wall St. Rank hold GRI as of Q2 2024.

  • Altium Capital Management reported no remaining GRI Bio position as of Q2 2024 after selling out during the quarter.
  • Altium Capital Management sold 30 GRI Bio shares in Q2 2024, an estimated $143K.
  • Altium Capital Management first reported a position in GRI Bio in Q2 2023 and held it in 3 quarters.
  • Altium Capital Management's GRI Bio position peaked at $5.01M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held GRI Bio as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.